Rakshni Kokilakumar
Atlanta, GANPI 1508639220
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 211 payments — averaging $34.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$818
- Galderma Laboratories, L.p.$781
- Novartis$747
- Arcutis Biotherapeutics, Inc.$656
- Johnson & Johnson$611
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,07796%
- Education$2684%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 25 | $1,119 |
| Regeneron Healthcare Solutions, Inc. | 17 | $818 |
| Galderma Laboratories, L.p. | 16 | $781 |
| Novartis | 22 | $747 |
| Arcutis Biotherapeutics, Inc. | 18 | $656 |
| Johnson & Johnson | 12 | $611 |
| AbbVie | 20 | $351 |
| Lilly USA, LLC | 9 | $263 |
| Dermavant Sciences, Inc. | 3 | $255 |
| Organon | 8 | $240 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $198 |
| Botanix SB Inc | 3 | $193 |
| Pfizer | 8 | $187 |
| Boehringer Ingelheim | 3 | $145 |
| Mallinckrodt Hospital Products Inc. | 3 | $134 |
| Sun Pharmaceutical Industries Inc. | 7 | $125 |
| E.r. Squibb & Sons, L.L.C. | 7 | $118 |
| Paratek Pharmaceuticals, Inc. | 4 | $89 |
| LEO Pharma Inc. | 3 | $73 |
| Amgen | 3 | $54 |
| Sanofi | 2 | $49 |
| Janssen Scientific Affairs, LLC | 2 | $48 |
| Incyte Corporation | 2 | $36 |
| Octapharma USA, Inc. | 1 | $21 |
| Almirall LLC | 1 | $19 |
| BD | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $379 |
| MethotrexateMethotrexate Sodium | 11 | $158 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.